This development marks a crucial step forward in SMSbiotech's efforts to address this debilitating respiratory condition. The Phase I trial, conducted in Australia, will be the first human trial of ...
SMSbiotech has announced a significant milestone in its pursuit of its regenerative medicine technology, securing approval to commence a Phase I clinical trial in Australia (registration number: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results